Diltiazem (Cardizem)

Diltiazem, commonly marketed under the brand name Cardizem, is a calcium channel blocker that has become an important medication in feline cardiology. This drug belongs to the benzothiazepine class of calcium channel blockers and is widely used to manage various cardiac conditions in cats. Diltiazem works by affecting the movement of calcium into heart muscle cells and blood vessel walls, which helps regulate heart rhythm and reduce blood pressure. In veterinary medicine, diltiazem has established itself as a valuable therapeutic option for cats suffering from heart disease, particularly those with rhythm disturbances or hypertrophic cardiomyopathy.

The mechanism of action of diltiazem involves blocking L-type calcium channels in cardiac and smooth muscle tissue. When calcium entry into cells is reduced, the heart rate slows, the force of cardiac contractions may decrease, and blood vessels dilate. This combination of effects makes diltiazem particularly useful for managing conditions where the heart is beating too fast or working too hard. The drug also has effects on the electrical conduction system of the heart, helping to slow conduction through the atrioventricular node, which is beneficial in treating certain types of arrhythmias commonly seen in feline patients.

Diltiazem is available in several formulations suitable for feline use, including immediate-release tablets, extended-release capsules, and injectable solutions for hospital or emergency use. The oral forms are most commonly prescribed for long-term management at home, while injectable diltiazem is typically reserved for acute situations requiring rapid heart rate control. Immediate-release tablets are usually given two to three times daily, though extended-release formulations may allow for less frequent dosing in some cases. Many cats tolerate oral administration reasonably well, though some owners may need to use pill pockets or other techniques to facilitate medication delivery.

The safety profile of diltiazem in cats is generally favorable when the medication is used appropriately under veterinary supervision. However, because this drug directly affects cardiac function and blood pressure, proper dosing and monitoring are essential. Cats receiving diltiazem require regular veterinary checkups to assess their response to therapy and to monitor for any adverse effects. Blood pressure measurement, electrocardiogram evaluation, and echocardiography may be recommended periodically to ensure the medication is working effectively without causing complications. Pet owners should never adjust doses or discontinue this medication without consulting their veterinarian, as sudden changes can have serious consequences for cats with heart disease.

The primary indication for diltiazem in cats is the management of hypertrophic cardiomyopathy, the most common form of heart disease affecting felines. Hypertrophic cardiomyopathy causes abnormal thickening of the heart muscle, which can impair the heart's ability to fill properly and may lead to arrhythmias, heart failure, or blood clot formation. Diltiazem helps manage this condition by slowing the heart rate, allowing more time for the ventricles to fill during each cardiac cycle, and reducing the oxygen demand of the heart muscle. Many cats with hypertrophic cardiomyopathy benefit from diltiazem therapy, particularly those experiencing rapid heart rates or showing signs of diastolic dysfunction.

Beyond hypertrophic cardiomyopathy, diltiazem serves as a first-line treatment for various supraventricular arrhythmias in cats. Supraventricular tachycardia, atrial fibrillation, and atrial flutter are rhythm disturbances that originate in the upper chambers of the heart and can cause dangerously rapid heart rates. Diltiazem's ability to slow conduction through the atrioventricular node makes it effective at controlling ventricular response rates in these conditions, even if it does not completely eliminate the underlying arrhythmia. By keeping the heart rate within a more normal range, diltiazem helps improve cardiac output and reduces symptoms associated with rapid heart rates.

Veterinarians also prescribe diltiazem for the management of systemic hypertension in cats, either as a primary therapy or in combination with other antihypertensive medications. High blood pressure is relatively common in older cats and is frequently associated with chronic kidney disease or hyperthyroidism. Uncontrolled hypertension can damage the eyes, kidneys, brain, and heart, making effective treatment essential. Diltiazem causes relaxation of blood vessel walls, which helps lower blood pressure and reduce the workload on the heart. In hypertensive cats, this medication may be combined with other drugs such as amlodipine to achieve optimal blood pressure control.

Additional clinical applications of diltiazem in feline medicine include its use in managing cats with both cardiac disease and concurrent hyperthyroidism. Hyperthyroidism commonly causes increased heart rate and can exacerbate underlying heart conditions. Diltiazem can help control heart rate while the underlying thyroid condition is being addressed with other treatments. The drug may also be used in emergency settings to rapidly control heart rate in cats presenting with severe tachyarrhythmias, where the intravenous formulation allows for quick onset of action and careful titration of effect.

When selecting diltiazem for a feline patient, veterinarians consider several factors including the specific cardiac diagnosis, the cat's overall health status, concurrent medications, and the expected duration of therapy. Diltiazem is often chosen over other rate-controlling medications when its particular combination of effects on heart rate, blood pressure, and cardiac relaxation is most beneficial. For cats with hypertrophic cardiomyopathy specifically, diltiazem may be preferred over beta-blockers in certain situations due to its favorable effects on diastolic function. The relatively predictable response to diltiazem in cats and its established safety record make it a commonly selected option for long-term cardiac management.

Dosing of diltiazem in cats requires careful individualization based on the patient's weight, specific cardiac condition, severity of disease, and response to therapy. Veterinarians determine the appropriate dose for each cat after thorough cardiac evaluation, and pet owners should never attempt to adjust doses without professional guidance. Weight-based dosing is standard practice, as cats vary significantly in size from small individuals weighing only a few pounds to larger cats exceeding fifteen pounds. The starting dose is typically conservative, with gradual increases as needed to achieve therapeutic goals while monitoring for adverse effects.

For immediate-release diltiazem tablets, the typical dosing range in cats falls between 1.75 to 2.5 milligrams per kilogram of body weight, administered two to three times daily. Some cats may require doses at the higher end of this range, while others respond well to lower doses. The frequency of administration is important because immediate-release diltiazem has a relatively short duration of action, and maintaining consistent blood levels requires multiple daily doses. Extended-release formulations, when used, may allow for once or twice daily dosing, though these formulations must be used carefully in cats as they are designed for human patients and cannot be divided or crushed.

The duration of diltiazem therapy depends entirely on the underlying condition being treated. For cats with hypertrophic cardiomyopathy or chronic arrhythmias, treatment is typically lifelong, as these conditions cannot be cured but can be managed with ongoing medication. The goal is to maintain quality of life, prevent complications, and manage symptoms over the long term. Cats receiving diltiazem for temporary conditions, such as rate control during treatment of hyperthyroidism, may eventually be weaned off the medication once the underlying condition is resolved. Regular veterinary reassessment helps determine whether continued therapy is necessary and whether dose adjustments are needed.

Administering diltiazem to cats can be accomplished using several techniques depending on the individual cat's temperament and the owner's skill. The tablets can be given directly by mouth, hidden in a small amount of food or a commercial pill pocket, or compounded into flavored liquid formulations for cats that resist taking pills. When giving diltiazem orally, it can generally be administered with or without food, though giving with a small amount of food may help reduce the likelihood of stomach upset. Consistency in administration timing helps maintain stable blood levels and optimal therapeutic effect.

If a dose of diltiazem is missed, pet owners should give the missed dose as soon as they remember, unless it is nearly time for the next scheduled dose. In that case, the missed dose should be skipped and the regular dosing schedule resumed. Owners should never give a double dose to make up for a missed one, as this could cause serious adverse effects including dangerous drops in heart rate or blood pressure. If multiple doses are missed or if there is confusion about the dosing schedule, the veterinarian should be contacted for guidance on how to proceed safely.

Completing the prescribed course of therapy and continuing medication as directed is essential for cats on diltiazem. Unlike antibiotics where a defined treatment course may be given, cardiac medications like diltiazem are typically continued indefinitely for chronic conditions. Stopping the medication abruptly can lead to rebound effects and potentially dangerous worsening of cardiac symptoms. If discontinuation becomes necessary for any reason, it should be done gradually under veterinary supervision. Pet owners should contact their veterinarian promptly if they have concerns about continuing the medication or if they notice any changes in their cat's condition.

Diltiazem is generally well tolerated by most cats when administered at appropriate doses under veterinary supervision. The majority of feline patients experience no significant adverse effects during therapy, and any side effects that do occur are often mild and manageable. However, because diltiazem affects the cardiovascular system, pet owners should be aware of potential side effects and monitor their cats during treatment. Early recognition of adverse effects allows for prompt veterinary intervention and dose adjustment if needed.

The most commonly observed side effects of diltiazem in cats involve the gastrointestinal system. Some cats may experience decreased appetite, nausea, or vomiting, particularly when first starting the medication. These effects are usually mild and often resolve as the cat adjusts to the medication over the first week or two of treatment. Giving diltiazem with a small amount of food may help reduce gastrointestinal upset in sensitive individuals. Diarrhea or constipation may occasionally occur but are relatively uncommon. If gastrointestinal side effects persist or are severe, the veterinarian may recommend dose adjustment or switching to an alternative medication.

Moderate side effects that warrant veterinary attention include excessive slowing of the heart rate, known as bradycardia, and low blood pressure, called hypotension. These effects are extensions of diltiazem's therapeutic action and indicate that the dose may be too high for the individual cat. Signs that may suggest bradycardia or hypotension include lethargy, weakness, collapse, or fainting episodes. Some cats may also experience mild gum swelling or gingival hyperplasia with long-term use, which is a known effect of calcium channel blockers. Additionally, some cats may show behavioral changes such as increased sedation or decreased activity levels.

Serious side effects requiring immediate veterinary attention are uncommon but can occur. Severe bradycardia can lead to inadequate blood flow to vital organs and may manifest as extreme weakness, difficulty breathing, or loss of consciousness. Allergic reactions, while rare, can present as facial swelling, hives, difficulty breathing, or collapse and require emergency treatment. Signs of heart failure worsening, such as increased respiratory rate, open-mouth breathing, coughing, or reluctance to move, should prompt immediate veterinary evaluation. Diltiazem can also affect cardiac conduction, potentially causing heart block in susceptible individuals.

Rare side effects and long-term concerns with diltiazem use in cats include liver enzyme elevations, which can be detected through routine blood work monitoring. While clinically significant liver problems are uncommon, periodic blood testing helps ensure the medication is not causing organ damage. Some cats on long-term diltiazem therapy may develop tolerance, requiring dose adjustments to maintain efficacy. Pet owners should contact their veterinarian if they notice any concerning changes in their cat's behavior, appetite, activity level, breathing, or overall well-being during diltiazem therapy. Regular monitoring appointments allow for early detection of any problems and optimization of treatment.

Diltiazem should not be used in cats with known hypersensitivity or allergy to diltiazem or other calcium channel blockers. While true allergic reactions to diltiazem are rare in cats, any cat that has previously experienced an adverse reaction to this medication or related drugs should not receive it again. Cross-reactivity between different calcium channel blockers is possible, so cats that have reacted to one drug in this class may need to avoid others as well. Pet owners should inform the veterinarian of any previous medication reactions or adverse events their cat has experienced, even if they occurred with different medications.

Significant contraindications exist for cats with certain types of cardiac conditions. Diltiazem should generally be avoided in cats with severe bradycardia, as the drug's heart rate-lowering effects could dangerously slow an already slow heart rate. Cats with sick sinus syndrome or advanced atrioventricular block are typically not candidates for diltiazem therapy unless they have a pacemaker in place. Similarly, cats with severely depressed cardiac function or decompensated heart failure may not tolerate diltiazem's negative effects on heart contractility. In these situations, the risks of diltiazem use outweigh the potential benefits, and alternative treatments must be considered.

Organ dysfunction significantly affects the safe use of diltiazem in cats. Because diltiazem is metabolized by the liver and both the drug and its metabolites can affect various organs, cats with significant liver disease may not be appropriate candidates for this medication. Impaired liver function can lead to delayed drug metabolism, resulting in higher blood levels and increased risk of adverse effects. Cats with kidney disease, which is extremely common in older felines, may also require dose adjustments or alternative medications depending on the severity of renal impairment. Pre-treatment blood work helps identify cats with organ dysfunction who may need modified treatment approaches.

Life stage considerations also influence the appropriateness of diltiazem use. The safety of diltiazem during pregnancy has not been established in cats, and this medication should generally be avoided in pregnant queens unless the potential benefits clearly outweigh the risks to the developing kittens. Nursing cats present similar concerns, as diltiazem can pass into milk and potentially affect nursing kittens. The use of diltiazem in kittens requires particular caution due to immature organ systems and different drug metabolism compared to adult cats. Elderly cats, while often candidates for diltiazem therapy due to the increased prevalence of heart disease with age, may require lower starting doses and more frequent monitoring due to age-related changes in drug handling. Pet owners should ensure their veterinarian has a complete picture of their cat's health history, current medications, and reproductive status before beginning diltiazem therapy.

Informing the veterinarian of all medications, supplements, and over-the-counter products a cat is receiving is essential before starting diltiazem therapy. Drug interactions can significantly alter how diltiazem works, potentially leading to increased toxicity or reduced effectiveness. Even seemingly harmless supplements or herbal products can interact with cardiac medications, making complete disclosure critical for safe treatment. The veterinarian can then make informed decisions about drug selection and monitoring requirements based on the cat's complete medication profile.

Diltiazem has significant interactions with several drug classes commonly used in feline medicine. When combined with beta-blockers such as atenolol or propranolol, there is increased risk of excessive heart rate slowing, low blood pressure, and heart block. While these combinations are sometimes used intentionally under close supervision, they require careful dose titration and monitoring. Digoxin levels can be significantly increased by diltiazem, potentially leading to digoxin toxicity; cats receiving both medications need regular monitoring of digoxin blood levels. Other antiarrhythmic medications may have additive or synergistic effects with diltiazem, requiring careful consideration of the combined cardiac effects.

Drugs that affect liver metabolism can alter diltiazem blood levels and effectiveness. Medications that inhibit certain liver enzymes may increase diltiazem concentrations, raising the risk of side effects. Conversely, drugs that induce liver enzymes may decrease diltiazem levels, potentially reducing its therapeutic effect. Certain antibiotics, antifungal medications, and other drugs can affect diltiazem metabolism, making it important to review potential interactions whenever new medications are prescribed. Grapefruit juice, while not commonly given to cats, can also affect diltiazem metabolism and should be avoided.

Food and supplement interactions should be considered for cats on diltiazem therapy. While diltiazem can generally be given with or without food, high-fat meals may affect absorption of some formulations. Calcium supplements could theoretically interfere with a calcium channel blocker's mechanism of action, though the clinical significance in cats is not well established. Herbal supplements, particularly those with cardiovascular effects such as hawthorn, should be used with caution or avoided. The veterinarian should be consulted before giving any new supplements to a cat receiving diltiazem. Monitoring for signs of drug interactions includes watching for excessive sedation, weakness, changes in heart rate, or other new symptoms after starting any new medication or supplement.

General precautions for diltiazem use in cats center on the need for careful dosing, regular monitoring, and close communication between pet owners and veterinarians. Because diltiazem directly affects cardiac function, even small changes in dose can have significant effects. Accurate measurement of doses is essential, and tablets should not be split or crushed unless specifically approved by the veterinarian, as this can affect drug release characteristics. Cats should be weighed regularly to ensure doses remain appropriate as body weight changes. Pet owners should follow all veterinary instructions carefully and never make dose adjustments independently.

While breed-specific sensitivities to diltiazem have not been extensively documented in cats, certain breeds are predisposed to the cardiac conditions that diltiazem treats. Maine Coon cats, Ragdolls, British Shorthairs, and several other breeds have higher rates of hypertrophic cardiomyopathy, making them more likely to require diltiazem or similar medications. These cats may need cardiac screening before symptoms develop, and those receiving diltiazem should be monitored according to their veterinarian's recommendations. Individual variation in drug response exists within all breeds, so careful titration and monitoring are important regardless of breed.

Environmental and handling precautions apply to diltiazem as with all medications. The medication should be stored out of reach of children and other pets, as accidental ingestion could cause serious adverse effects. Pet owners handling diltiazem tablets do not generally need special protective measures, though washing hands after handling medication is good practice. In multi-pet households, care should be taken to ensure the correct cat receives the medication and that other animals do not have access to the drug. Compounded formulations may have specific handling requirements that should be reviewed with the pharmacist.

Monitoring during diltiazem therapy typically includes regular veterinary examinations, periodic blood pressure measurements, and cardiac evaluations as recommended by the veterinarian. Electrocardiograms may be performed to assess heart rhythm, and echocardiography helps evaluate the heart's structure and function over time. Blood work including liver and kidney function tests may be recommended periodically, particularly in older cats or those on multiple medications. Pet owners should monitor for signs of efficacy, such as improved activity level and breathing, as well as potential toxicity, including lethargy, weakness, or changes in appetite.

Special populations requiring additional caution include geriatric cats, who may have age-related decreases in liver and kidney function affecting drug metabolism and elimination. Senior cats may be more sensitive to diltiazem's blood pressure-lowering effects and may need lower doses. Kittens have immature organ systems and require careful dose calculation based on their smaller size. Cats with concurrent diseases, particularly kidney disease, liver disease, or other cardiac conditions, may need modified treatment protocols. Immunocompromised cats or those with chronic illnesses may require additional monitoring to ensure diltiazem is not contributing to any health declines.

Proper storage of diltiazem helps maintain the medication's effectiveness and safety throughout its shelf life. The tablets and capsules should be stored at controlled room temperature, typically between 68 and 77 degrees Fahrenheit, though brief exposures to temperatures between 59 and 86 degrees are generally acceptable. The medication should be protected from excessive heat, direct sunlight, and moisture, as these conditions can degrade the active ingredient or affect the drug's release characteristics. A cool, dry location such as a medicine cabinet away from the bathroom, where humidity can be high, is ideal for storage.

Different formulations of diltiazem may have specific storage requirements that should be followed carefully. Immediate-release tablets are generally stable at room temperature in their original packaging. Extended-release capsules may be more sensitive to moisture and should be kept in tightly closed containers. Injectable diltiazem used in hospital settings has its own storage requirements and is not typically dispensed for home use. Compounded formulations of diltiazem prepared by veterinary pharmacies may have different stability profiles and shorter expiration dates compared to commercial products, and owners should follow the specific storage instructions provided by the compounding pharmacy. Any medication that appears discolored, has an unusual odor, or shows visible degradation should not be used.

Safe handling and disposal of diltiazem protect both household members and the environment. The medication should be kept in its original container with the childproof cap secured when not in use. In households with children or pets who might accidentally access medications, additional precautions such as storing the medication in a locked cabinet may be appropriate. When diltiazem is no longer needed or has expired, it should be disposed of properly rather than thrown in the trash or flushed down the toilet. Many pharmacies and veterinary clinics participate in drug take-back programs that provide safe disposal options. The DEA also sponsors periodic take-back events. If no take-back options are available, the FDA provides guidelines for safe home disposal of medications.

Most cats can receive diltiazem therapy regardless of breed, as the medication's effects on the cardiovascular system are generally consistent across different feline breeds. However, breed does influence the likelihood of developing the cardiac conditions for which diltiazem is prescribed, and certain breeds may require earlier cardiac screening and potentially earlier intervention with medications like diltiazem. Veterinarians familiar with breed-specific health concerns can provide guidance on when cardiac evaluation is recommended and whether diltiazem or alternative medications might be most appropriate for individual patients.

Several cat breeds have documented predispositions to hypertrophic cardiomyopathy, the condition most commonly treated with diltiazem. Maine Coon cats and Ragdolls have well-established genetic mutations associated with hypertrophic cardiomyopathy, and genetic testing is available for breeding cats in these breeds. British Shorthairs, American Shorthairs, Persians, and Sphynx cats also show increased rates of this condition. Bengal cats, Devon Rex, and several other breeds have been reported to develop hypertrophic cardiomyopathy more frequently than the general cat population. Cats of these breeds may benefit from cardiac screening starting at an early age, and those diagnosed with heart disease may be candidates for diltiazem therapy depending on their specific presentation.

Body size varies considerably among cat breeds, which has practical implications for diltiazem dosing. Large breeds such as Maine Coons, which can weigh fifteen pounds or more, require correspondingly higher total doses to achieve therapeutic blood levels compared to smaller breeds. Conversely, petite breeds and small individual cats need precise dose calculations to avoid overdosing. The availability of different tablet strengths helps accommodate this size variation, but accurate patient weighing remains essential. Some very small cats may require compounded formulations to allow precise dosing that cannot be achieved by splitting commercially available tablets.

Age-related considerations apply across all breeds when using diltiazem. Kittens of any breed have immature liver and kidney function, which affects how they process and eliminate medications. Young cats may require adjusted dosing and more frequent monitoring until their organ systems fully mature. At the other end of the age spectrum, senior cats commonly experience age-related decline in organ function that can affect diltiazem metabolism and clearance. Older cats of breeds predisposed to kidney disease may need particularly careful monitoring when receiving diltiazem. Veterinarians consider both breed-specific factors and individual patient characteristics when developing treatment plans involving diltiazem for feline patients.

Several other medications share the same pharmacological class as diltiazem or serve similar therapeutic purposes in feline cardiology. Within the calcium channel blocker class, amlodipine is perhaps the most commonly used alternative in cats, though it is primarily employed for hypertension rather than arrhythmia control. Amlodipine belongs to the dihydropyridine subclass of calcium channel blockers and has more pronounced effects on blood vessels than on the heart, making it the preferred choice for systemic hypertension while diltiazem is typically favored when heart rate control is the primary goal. Verapamil is another non-dihydropyridine calcium channel blocker with effects similar to diltiazem, though it is used less commonly in cats.

Beta-blockers represent an alternative drug class frequently used for similar indications as diltiazem in cats. Atenolol is the most commonly prescribed beta-blocker for feline cardiac conditions and is often used for hypertrophic cardiomyopathy and various arrhythmias. Propranolol is a non-selective beta-blocker that may be used in certain situations, particularly when concurrent hyperthyroidism is present. These medications work through a different mechanism than diltiazem, blocking the effects of adrenaline on the heart rather than blocking calcium channels. The choice between diltiazem and a beta-blocker depends on the specific cardiac condition, individual patient factors, and the desired therapeutic effects.

Complementary therapies and supportive care may be used alongside diltiazem in cats with cardiac disease. Some cats benefit from dietary modifications, such as moderate sodium restriction, to support cardiovascular health. Omega-3 fatty acid supplements may have modest cardiovascular benefits and are sometimes recommended for cats with heart disease. Taurine supplementation is essential for cats with taurine deficiency cardiomyopathy, though this condition is now uncommon due to adequate taurine content in commercial cat foods. Importantly, pet owners should never substitute one medication for another or add supplements without veterinary guidance, as drug interactions and inappropriate combinations can have serious consequences. The veterinarian can provide comprehensive recommendations for managing feline heart disease using the most appropriate combination of medications and supportive measures.